Market Overview

ConnectOne Bancorp To Acquire Bancorp Of New Jersey For $113M

Share:

ConnectOne Bancorp, Inc. (NASDAQ: CNOB) will acquire Bancorp of New Jersey, Inc. (NYSE: BKJ) for $113 million or approximately $15.48 per Bancorp of New Jersey share.

Bancorp of New Jersey shareholders will receive for each share of Bancorp of New Jersey common stock either 0.78 shares of ConnectOne common stock or $16.25 in cash. The deal is expected to be completed in the first-quarter of 2020.

"This is a financially savvy, in-market acquisition with strong economics to enhance our powerful franchise. The accretive transaction demonstrates our commitment to deliver attractive long-term returns for our shareholders and strongly supports our defined growth strategy which includes opportunistic growth through M&A," said Frank Sorrentino, ConnectOne's CEO.

"Bancorp of New Jersey is a natural fit for ConnectOne given its commercial business focus, overlapping geographic footprint, shared client base and the considerable synergies that are expected. We look forward to continuing to deliver extraordinary client service to all Bancorp of New Jersey and ConnectOne clients, and enhancing value to our shareholders."

ConnectOne Bancorp shares were trading at $19.60 in Friday’s pre-market session. The stock has a 52-week high of $25.60 and a 52-week low of $17.07.

Related Links:

UPS's Venture Arm Makes Minority Investment In Autonomous Truck Company TuSimple

Sterling Construction Will Acquire Plateau Excavation In $400M Deal

Posted-In: M&A News

 

Related Articles (BKJ + CNOB)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission

Deere Reports Q3 Earnings Miss, Cuts Guidance